Oncology News, Insights, Stories by OncoDaily

Provider Education Series - Lung Health Foundation
2026-03-05 13:00 - 14:00 (America/Halifax) | Shinjuku
The Lung Health Foundation is offering a free, accredited virtual “Lunch and Learn” series – the Provider Education Series – consisting of three one-hour sessions designed to deliver high-impact, evidence-based education to healthcare professionals.
These sessions will provide practical insights from expert speakers on the diagnosis, treatment, and management of lung diseases, with a focus on severe asthma, COPD, and lung cancer. Participants will enhance their clinical knowledge, receive updates on current lung cancer risk assessment and screening guidelines, and earn valuable CPD credits to support best practices.

Session 1: September 18, 2025: What You Need to Know – Managing Severe Asthma in Your Practice
Session 2: November 27th, 2025: What You Need to Know – Optimizing COPD Treatment and Reducing Exacerbations in Your Practice
Session 3: March 5th, 2026: What You Need to Know – Managing Lung Cancer Risk Assessment in Your Practice

APPOS Charlotte 2026: Advanced Practice Providers Oncology Summit
2026-03-06 - 2026-03-07 | The Ballantyne Hotel, Charlotte, Ballantyne Commons Parkway Charlotte, Charlotte, 28277, United States
The APPOS Charlotte 2026: Advanced Practice Providers Oncology Summit returns to Charlotte on March 6–7, 2026, bringing oncology clinicians together for a focused, two-day CE program dedicated to the latest advances in cancer care.
Designed with and for advanced practice providers, this summit delivers evidence-based updates, practical management strategies, and collaborative learning to strengthen patient care and team communication across the oncology continuum.
Register.

Pathology Update 2026
2026-03-06 - 2026-03-08 | International Convention Centre Sydney, Australia, 14 Darling Dr, Sydney NSW 2000, Australia, Sydney, NSW, 2000, Australia
Pathology Update 2026 is the annual scientific conference hosted by The Royal College of Pathologists of Australia (RCPA). It will take place from March 6 to March 8, 2026, in Sydney, NSW.
The meeting provides a multi-disciplinary pathology program for pathologists, scientists, and trainees, focusing on new developments and challenges in the field under the theme, “Many Paths. Shared Focus. Stronger Together.” The event will include plenary sessions, workshops, and abstract presentations from both local and international pathology experts, coinciding with the celebration of the RCPA’s 70th anniversary.

26th Multidisciplinary Management of Cancers: A Case-Based Approach
2026-03-06 08:00 - 2026-03-08 12:15 (America/Halifax) | The Meritage Resort and Spa, 875 Bordeaux Way, Napa, CA, 94558, United States
The 26th Multidisciplinary Management of Cancers: A Case-Based Approach, held March 6–8, 2026, at the Meritage Resort and Spa, will focus on the latest multidisciplinary strategies in clinical oncology.
The meeting features tumor board–style case discussions across breast, gastrointestinal, genitourinary, hematologic, lymphoma, and thoracic cancers, led by faculty and expert panels from Stanford, UC Davis, UC San Francisco, and the broader oncology community.
Register here.

OPN Pacific Northwest Chapter Conference 2026
2026-03-07 | Crowne Plaza Portland-Downtown Conv Ctr, 1441 NE 2nd Ave, Portland, OR, 97232, United States
The OPN Pacific Northwest Chapter Conference 2026 is a one-day regional summit organized by the Oncology Pharmacy Network, scheduled for March 7, 2026.
The conference will be held at the Crowne Plaza in Portland, Oregon, United States. Designed for hematology/oncology pharmacy clinicians, including pharmacists and technicians, the event provides a platform to network, collaborate, and share the latest evidence-based strategies and best practices to advance patient care within the oncology pharmacy field.
Register.

ESMO - The Christie Preceptorship on Lung Cancer 2026: Manchester
2026-03-11 - 2026-03-13 | Manchester, United Kingdom
The ESMO – The Christie Preceptorship on Lung Cancer 2026: Manchester will be held from March 11-13, 2026, in Manchester, United Kingdom.
The application deadline is January 21, 2026, at 23:59 CET, and the course is accredited for 16 ESMO-MORA category 1 points.
The learning objectives cover the full spectrum of thoracic oncology, from screening and management of early-stage non-small cell lung cancer (NSCLC) to multi-modality treatment for locally advanced disease and systemic therapy for mesothelioma and small-cell lung cancer (SCLC), with a focus on advanced treatments like targeted agents for actionable driver mutations, novel immunotherapies, and palliative care.
Apply.

12th ImmunoTherapy of Cancer Conference (ITOC12)
2026-03-12 - 2026-03-14 | Medical Center Großhadern of Ludwig-Maximilian-University, Marchioninistrasse 15, Munich, 81377, Germany
The 12th ImmunoTherapy of Cancer Conference (ITOC12) is a European meeting scheduled to take place from March 12 – 14, 2026, in Munich, Germany. The conference provides a global platform focused on translational research in immuno-oncology, serving as a forum for the discussion of early clinical translation and its unique challenges. Organized by WMA GmbH in scientific cooperation with various international groups, including the ITOC Association, the Tumor Centre in Munich (TZM), and the German Cancer Consortium (DKTK), the main goal is to allow those dedicated to the immunotherapy of cancer to exchange their knowledge and latest findings to advance oncology drug development and delivery.

The ESMO Sarcoma and Rare Cancers Congress 2026
2026-03-12 08:00 - 2026-03-14 17:00 (Europe/Zurich) | “Palazzo dei Congressi” in Lugano, Switzerland, Piazza Indipendenza 4, Lugano, 6900, Switzerland
The ESMO Sarcoma and Rare Cancers Congress 2026 will take place from 12–14 March in Lugano, Switzerland, offering a premier platform for experts to share cutting-edge research and innovative treatment approaches in rare solid tumours.
The congress will discuss the latest developments in diagnosis, treatment, molecular biology, and classification of sarcomas and other rare cancers. The programme includes a wide range of sessions such as abstract presentations, educational lectures, multidisciplinary tumour boards, guidelines updates, and dedicated discussions for young oncologists. With opportunities for clinicians, researchers, industry professionals, and patient advocates to connect and collaborate, the congress promises three days of enriching scientific exchange and community building in the field of rare cancers.

APPOS Boston 2026: Advanced Practice Providers Oncology Summit
2026-03-13 - 2026-03-14 | The Westin Waltham Boston, 70 Third Ave., Waltham, MA, 02451, United States
The APPOS Boston 2026: Advanced Practice Providers Oncology Summit returns to Massachusetts, a two-day continuing education conference taking place March 13–14, 2026, in Waltham.
Designed for advanced practice providers, this program delivers the latest updates in multidisciplinary cancer care, practical patient management, and interprofessional collaboration. Attendees will have the opportunity to earn CE credits while gaining evidence-based strategies to enhance oncology practice and improve communication across the healthcare team.
Register.

Inaugural Oncology Nursing Symposium 2026
2026-03-13 - 2026-03-14 | Embassy Suites by Hilton Charlotte Concord Golf Resort & Spa, 5400 John Q. Hammons Dr NW, Concord, NC, 28027, United States
The Inaugural Oncology Nursing Symposium 2026, hosted by the South Piedmont AHEC in conjunction with Advocate Health, is a crucial two-day, in-person event for nurses, scheduled for March 13–14, 2026.
The symposium will be held at the Embassy Suites by Hilton Charlotte Concord in Concord, North Carolina. This educational gathering is aimed at a wide audience of oncology nurses, including frontline clinicians, nurse leaders, educators, and researchers, and is accredited for a maximum of 7.50 ANCC contact hours.
Agenda and Details.
Register.

2026 CRUSH Colorectal Cancer 5K
2026-03-14 | The River Church, 4425 Ben Franklin Blvd., Durham, NC, 27704, United States
The CRUSH Colorectal Cancer 5K Walk/Run, which supports research at the Duke Cancer Institute, will take place on Saturday, March 14, 2026, at 10:00 a.m.
The event will be held at The River Church. This event aims to raise awareness for colorectal cancer, provide access to colorectal cancer screenings, and feature community exhibitors.

2026 OPN California - Hawaii Chapter Conference
2026-03-14 | Sheraton Park Hotel at the Anaheim Resort, 1855 S Harbor Blvd, Anaheim, CA, 92802, United States
The 2026 OPN California – Hawaii Chapter Conference is a one-day regional summit organized by the Oncology Pharmacy Network (OPN) and Horizon CME, scheduled for March 14, 2026, at the Sheraton Park Hotel at the Anaheim Resort in Anaheim, California, United States.
This event is specifically designed for hematology/oncology pharmacy clinicians (pharmacists, pharmacy technicians, and other healthcare professionals) and focuses on optimizing cancer care by providing the latest evidence-based strategies and fostering networking and collaboration within the community.
Register.

Cancer Immunotherapy: Basic Mechanisms Informing Clinical Applications and Combinations
2026-03-15 - 2026-03-18 | Fairmont Le Château Frontenac, 1 Rue des Carrières, Québec, Québec, G1R 5J5, Canada
The Keystone Symposia conference, “Cancer Immunotherapy: Basic Mechanisms Informing Clinical Applications and Combinations,” will be held from March 15–18, 2026, at the Fairmont Le Château Frontenac in Québec City, Québec, Canada.
This meeting brings together leading experts from academia, industry, and clinical medicine to examine the limitations of current immunotherapies and the mechanisms of resistance, with the goal of guiding strategies to overcome these hurdles and improve clinical outcomes; the sessions will highlight emerging research on targeting stromal and myeloid cells, tumor recognition, and advanced technologies like spatial imaging and AI.

ESMO Targeted Anticancer Therapies Congress 2026
2026-03-16 - 2026-03-18 | Palais des Congrès de Paris, 2 Pl de la Pte Maillot, Paris, Île-de-France, 75017, France
The ESMO Targeted Anticancer Therapies (TAT) Congress 2026 is a major scientific forum organized by the European Society for Medical Oncology (ESMO), focused on accelerating the delivery of life-changing anticancer therapies through early drug development.
The congress will be held from March 16 to 18, 2026, at the Palais des Congrès in Paris, France. The event serves as a dynamic, multi-stakeholder meeting, uniting researchers, industry leaders, investors, and regulators to share new data, foster collaboration, and tackle the challenges of advancing early clinical development in oncology.
Elena Garralda, Carlos Gomez-Roca, and Cristian Massacesi serve as the co-chairs.

The Tumour Ecosystem: From Mechanisms to Novel Therapeutics
2026-03-17 - 2026-03-19 | Centro Congressi Giovanni XXIII, Viale Papa Giovanni XXIII, 106, Bergamo, Lombardy, 24121, Italy
The EACR conference on The Tumour Ecosystem: From Mechanisms to Novel Therapeutics will be held from 17 to 19 March 2026 in Bergamo, Italy. Organized by the European Association for Cancer Research (EACR), the event’s venue is the Centro Congressi Giovanni XXIII. The conference will focus on the latest research in the tumor microenvironment, covering how cancer cells interact with the immune system, stroma, and nervous system, with the goal of developing new and efficient therapeutic strategies.
You can find more posts featuring EACR on OncoDaily.

From Protocol to Publication: A Practical Course in Clinical Research
2026-03-17 - 2026-03-19 | Shinjuku
The “From Protocol to Publication: A Practical Course in Clinical Research” is an exclusive, in-person training event organized by the European School of Oncology (ESO). Scheduled for 17 to 18 March 2026 in Milan, Italy, this advanced, two-day workshop is reserved only for the ten members of the ESO College who achieve the highest scores in two prerequisite online courses.
Led by Course Leaders Luca Bertolaccini (IT) and Isabelle Schmitt-Opitz (DE/CH), the course offers highly interactive sessions, hands-on workshops, and peer-review simulations designed to bridge the gap between theoretical knowledge and real-world research practice, covering every phase from protocol design to publication strategies.
You can find more posts featuring ESO on OncoDaily.

TROG Annual Scientific Meeting 2026
2026-03-17 - 2026-03-20 | Pullman Melbourne Albert Park, 65 Queens Rd, Albert Park VIC 3004, Australia, Melbourne, Victoria, 3004, Australia
The 38th TROG Annual Scientific Meeting (ASM), hosted by the Trans-Tasman Radiation Oncology Group (TROG) Cancer Research, will be held in Melbourne from March 17 to 20, 2026.
The conference theme is “Driving Intelligent Trials,” which focuses on using smarter designs, AI-driven insights, and stronger trial systems to achieve better research outcomes in radiation oncology.
The meeting’s sub-themes include: Precision and Performance (for smarter, AI-enabled trial designs), Equity in Motion (for research involving consumers, underserved, rural, and First Nations populations), and Fuelling the Future (for sustaining a strong research workforce and embedding research into clinical care). The ASM will serve as a key platform for collaboration, learning, and professional exchange on the latest developments in clinical trials and innovation in practice.

The ICHNO 2026
2026-03-19 08:00 - 2026-03-21 17:00 (Europe/Madrid) | Fibes – Conference and Exhibition, Ave. Alcalde Luis Uruñuela, 1, Seville, 41020, Spain
The ICHNO 2026, the 10th International Congress on Innovative Approaches in Head and Neck Oncology, will be held from 19–21 March 2026 in Seville, Spain, under the theme: “Driven by Biology, Centred on the Person.”
This unique event—jointly organized by ESTRO, EHNS, and ESMO—will bring together the full spectrum of multidisciplinary expertise to explore the latest advances in head and neck oncology, grounded in biology and focused on the individual.
With global thought leaders, impactful research, and opportunities for meaningful dialogue, ICHNO 2026 will be a vital platform for education, exchange, and collaboration. The Chairpersons of the 10th ICHNO Congress are Mererid Evans (ESTRO), Giovanni Succo (EHNS), and Yungan Tao (ESMO).
More posts featuring European Society for Radiotherapy and Oncology on OncoDaily.

ANZGOG 2026 Annual Scientific Meeting
2026-03-25 - 2026-03-27 | Gold Coast Convention and Exhibition Centre, 2684 - 2690 Gold Coast Highway, Broadbeach, Queensland, 4218, Australia
The ANZGOG 2026 Annual Scientific Meeting is a flagship event of the Australian New Zealand Gynaecological Oncology Group (ANZGOG). The 2026 ASM, themed “On the Edge: Translating Innovation into Action,” is scheduled for March 25–27, 2026, on the Gold Coast, Queensland.
It serves as a dynamic forum for national and international experts – including gynaecological medicine, radiation, and surgical oncologists, researchers, nurses, and industry partners – to engage in bold thinking and action-oriented discussion focused on the future of gynaecological cancer research, particularly around emerging technologies like artificial intelligence, the urgent need for pragmatic trials, and transforming insights from molecular studies and the lived experience of survivors into clinical impact.

2026 SITC Spring Scientific: Enhancing Cellular Therapies with Next-generation IO Molecules
2026-03-25 - 2026-03-27 | El Conquistador Tucson, A Hilton Resort, 10000 N Oracle Rd, Tucson, AZ, 85704, United States
The 2026 SITC Spring Scientific: Enhancing Cellular Therapies with Next-generation IO Molecules will be held from March 25–27, 2026, in a hybrid format with options to attend in Tucson, Arizona, or virtually.
Organized by the Society for Immunotherapy of Cancer (SITC), the program will bring together experts in cell therapy, drug development, and immuno-oncology to focus on the timely topic of combining next-generation immuno-oncology agents with cellular therapies to treat cancer.
The organizing com
mittee includes Kristen Hege, MD, Gordon Moody, MS, Daniel Powell, Jr., PhD, and Evan Weber, PhD, and registration for the event opens on August 18, 2025.
Register.
Abstract Submission.

The European Lung Cancer Congress (ELCC 2026)
2026-03-25 08:00 - 2026-03-28 17:00 (Europe/Copenhagen) | Bella Center, Center Boulevard 5, Copenhagen, 2300, Denmark
The European Lung Cancer Congress (ELCC 2026) will take place from 25–28 March 2026 in Copenhagen, Denmark, bringing together leading multidisciplinary societies dedicated to thoracic oncology. This congress serves as a key platform for advancing science, sharing education, and enhancing lung cancer care practices globally.
With a comprehensive programme designed for medical oncologists, radiation oncologists, thoracic surgeons, respiratory physicians, interventional radiologists, and pathologists, ELCC 2026 offers valuable learning and networking opportunities. Participants are invited to engage in interactive sessions and connect with lung cancer specialists from around the world.

Stereotactic Radiotherapy and Radiosurgery for Brain Metastases and Skull Base Lesions
2026-03-26 - 2026-03-28 | Ospedale Isola Tiberina – Gemelli Isola, Via di Ponte Quattro Capi, 39, Rome, Rome Metropolitan City, 00186, Italy
The ESTRO course on Stereotactic Radiotherapy and Radiosurgery for Brain Metastases and Skull Base Lesions will take place in Rome, Italy, from March 26–28, 2026.
`Directed by Maximilian Niyazi, this course is designed to allow radiation oncologists, medical physicists, radiation therapists, and other specialists to deepen their expertise and master advanced SRS/SRT techniques specifically for treating complex cases like brain metastases and skull base lesions, with an emphasis on practical, real-world clinical guidance. The early registration deadline for the course is January 7, 2026.

2026 Japanese Society of Medical Oncology Annual Meeting
2026-03-26 - 2026-03-28 | PACIFICO Yokohama, 1 Chome-1-1 Minatomirai, Nishi Ward, Yokohama, Kanagawa, 220-0012, Japan
The 23rd Annual Meeting of the Japanese Society of Medical Oncology (JSMO2026) will take place from March 26–28, 2026, at PACIFICO Yokohama North and Exhibition Hall D in Yokohama, Japan.
Centered on the theme “Medical Oncologists for Cancer Patients,” this year’s meeting marks the 20th anniversary of JSMO’s board certification program and offers a timely opportunity to reflect on the evolving role of medical oncologists in cancer care, research, and multidisciplinary practice. JSMO2026 will highlight cutting-edge evidence, Asian-led oncology advances, and future directions in education, collaboration, and patient-centered cancer care.
Register.

Summit on Cancer Health Disparities (SCHD26)
2026-03-27 - 2026-03-28 | Hyatt Regency Bellevue on Seattle’s Eastside, 900 Bellevue Way NE, Bellevue, WA, 98004, United States
The Summit on Cancer Health Disparities (SCHD26) is a two-day conference organized by Binaytara, scheduled for March 27–28, 2026, at the Hyatt Regency Bellevue in Bellevue, Washington, United States.
This summit is dedicated to addressing the critical issue of cancer health disparities. Attendees can earn up to 12.75 credits, and the conference is designed to bring together healthcare professionals to learn about and collaborate on strategies to improve equity and access in cancer care.
Register.

Application of External Control Arms in Oncology Drug Development
2026-04-07 10:00 - 14:00 (America/Halifax) | The Ritz-Carlton, Washington, D.C, 1150 22nd St NW, Washington, DC, 20037, United States
The public meeting, “Application of External Control Arms in Oncology Drug Development,” hosted by Friends of Cancer Research, is scheduled for Tuesday, April 7, 2026, from 10:00 AM to 2:00 PM ET, at The Ritz-Carlton in Washington, DC, with a virtual streaming option available.
The purpose of the meeting is to explore opportunities for advancing the use of External Control Arms (ECAs), which are constructed from existing data sources like prior clinical trials or real-world data, to enhance oncology drug development, particularly when traditional randomized trials are impractical.
Register.

SIOG Research Masterclass 2026
2026-04-08 - 2026-04-10 | Hilton St. Petersburg Bayfront, 333 1st St SE, Saint Petersburg, FL, 33701-4342, United States
The SIOG 2026 Research Masterclass is an intensive, three-day course organized by the International Society of Geriatric Oncology (SIOG), running from April 8 to April 10, 2026. The event will be held at the Hilton St. Petersburg Bayfront in Tampa, Florida, U.S..
Its core focus is to equip early-career clinical investigators and other professionals with essential attributes for designing clinical studies that are centered on the currently underrepresented older adult cancer population. The objective is to provide world-class training to address hidden inclusion criteria that often exclude older cancer patients from randomized control studies.

Texas Lung Cancer Conference 2026
2026-04-09 - 2026-04-11 | ACL Live at the Moody Theater, 310 W 2nd St, Austin, Austin, Texas, 78701
The 2026 Texas Lung Cancer Conference (TLC 2026) is scheduled to take place from April 9 to 11, 2026, at ACL Live at The Moody Theater in Austin, Texas. This CE-accredited, in-person event will convene over 100 leading national experts, rising faculty, and community oncologists for two days of case-driven education focused on the latest advancements in lung cancer diagnosis, treatment, and patient-centered care.
thetlcconference.com
The conference is co-chaired by Dr. Tina Cascone of MD Anderson Cancer Center and Dr. Stephen Liu of Georgetown University. Attendees can expect a dynamic program featuring panel discussions, interactive sessions, and networking opportunities.
The event will also host a scientific poster competition, with abstract submissions due by November 28, 2025, and winners notified by December 12, 2025.
Hotel accommodations and additional conference activities will be held at The W Austin, located adjacent to ACL Live by a connecting walkway. Attendees are encouraged to reserve their rooms early to take advantage of the TLC special group rate.
You can find more posts on the Texas Lung Cancer Conference on OncoDaily.

APPOS Tampa 2026: Advanced Practice Providers Oncology Summit
2026-04-10 - 2026-04-11 | The Westin Tampa Waterside, 725 South Harbour Island Boulevard, Tampa, FL, 33602, United States
The APPOS Tampa 2026: Advanced Practice Providers Oncology Summit will be held April 10–11, 2026, in Tampa, Florida, USA.
This two-day conference is designed for advanced practice providers—including nurse practitioners, physician assistants, pharmacists, and oncology nurses—and focuses on evidence-based strategies for the multidisciplinary treatment and management of oncology patients. Attendees can earn continuing education (CE) credits while learning practical approaches to improve patient care and interprofessional collaboration.
Register.

2026 Highlights of ASH in Asia-Pacific
2026-04-10 - 2026-04-11 | Shangri-La Kuala Lumpur, 11, Jln Sultan Ismail, Kuala Lumpur, Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, 50250, Malaysia
The 2026 Highlights of ASH in Asia-Pacific is a two-day program co-hosted by the American Society of Hematology (ASH) and the Malaysian Society of Hematology.
The event is scheduled for April 10–11, 2026, in Kuala Lumpur, Malaysia, bringing together global hematology leaders to discuss the most influential and novel research presented at the latest ASH Annual Meeting.
The conference, which is curated for hematologists, oncologists, fellows, and other health professionals, will cover a wide range of malignant and classical hematology topics, including Acute Myeloid/Lymphoblastic Leukemia, Hemoglobinopathies, Plasma Cell Disorders, and Thrombosis.
Register.

2026 OPN Florida Chapter Conference
2026-04-11 | The Westin Tampa Waterside, 725 South Harbour Island Boulevard, Tampa, FL, 33602, United States
The 2026 OPN Florida Chapter Conference, organized by the Oncology Pharmacy Network (OPN) and Horizon CME, is a single-day event for hematology/oncology pharmacy clinicians, including pharmacists and technicians, to share best practices and enhance their expertise in cancer care.
Scheduled for April 11, 2026, the conference will take place at The Westin Tampa Waterside in Tampa, Florida, United States. The program is set to cover the latest evidence-based strategies, including updates on small cell lung cancer, follicular lymphoma, treatments for non-muscle invasive bladder cancer, and AML updates on menin inhibitors. Attendees can earn up to 6.00 continuing education credits.
